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Abstract
Background: Although obesity is a well-studied risk factor for diabetes, there remains an interest in whether
“increasing body mass index (BMI),” “high BMI per se,” or both are the actual risk factors for diabetes. The present
study aimed to retrospectively compare BMI trajectories of individuals with and without diabetes in a case–control
design and to assess whether increasing BMI alone would be a risk factor.
Methods: Using comprehensive health check-up data measured over ten years, we conducted a case–control
study and graphically drew the trajectories of BMIs among diabetic patients and healthy subjects, based on
coefficients in fitted linear mixed-effects models. Patient group was matched with healthy control group at the
onset of diabetes with an optimal matching method in a 1:10 ratio. Simple fixed-effects models assessed the
differences in increasing BMIs over 10 years between patient and control groups.
Results: At the time of matching, the mean ages in male patients and controls were 59.3 years [standard deviation
(SD) = 9.2] and 57.7 years (SD = 11.2), whereas the mean BMIs were 25.0 kg/m2 (SD = 3.1) and 25.2 kg/m2 (SD = 2.9),
respectively. In female patients and controls, the mean ages were 61.4 years (SD = 7.9) and 60.1 years (SD = 9.6),
whereas the mean BMIs were 24.8 kg/m2 (SD = 3.5) and 24.9 kg/m2 (SD = 3.4), respectively. The simple fixed-effects
models detected no statistical significance for the differences of increasing BMIs between patient and control
groups in males (P = 0.19) and females (P = 0.67). Sudden increases in BMI were observed in both male and female
patients when compared with BMIs 1 year prior to diabetes onset.
Conclusions: The present study suggested that the pace of increasing BMIs is similar between Japanese diabetic
patients and healthy individuals. The increasing BMI was not detected to independently affect the onset of type
2 diabetes.
Keywords: Diabetes mellitus, Type 2, Body mass index, Aging, Blood glucose, Hyperglycemina, Hemoglobin A,
Glycated, Metabolic syndrome X, General linear models, Case–control studies, Retrospective studies
Background
The worldwide population of individuals with diabetes is
more than 382 million people [1], and potentially, 20.5
million of these are in Japan [2]. Because the subsequent
ischemic heart disease, cerebral infarction, retinopathy,
nephropathy, and neuropathy are life threatening to
numerous people, the prevention of diabetes is of
great importance. Among many environmental
factors associated with diabetes, obesity is a particu-
larly well-known risk factor for type 2 diabetes [3–5].
Notably, studies indicate that East Asian individuals
with body mass indexes (BMIs) within normal range
are much more likely to develop diabetes compared
with Caucasians and African Americans with those
BMIs [6].
Several studies have indicated that individuals with
high BMIs are at a high risk of developing diabetes,[7–
13]; however, due to their cross-sectional or 2–3 time-
point cohort designs, these reports have not distin-
guished the risk of “increasing BMI” on diabetes onsets
from that of “high BMI per se.” The present study from
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Japanese large-scale clinical data was driven by the inter-
est in comparing BMI trajectories in diabetic patients
and healthy individuals and by the question of whether
increasing BMI alone would cause diabetes.
Methods
Ethics statement
This study was approved by the Ethical Review Board
of the Faculty of Medicine, University of Yamanashi
(approval number: H22 No.620). Approval was based
on the ethical guidelines and regulations of the Declaration
of Helsinki. The Japanese guidelines permit the use of data
from medical check-ups without consent if the data are an-
onymous. Hence, informed consent was not required in
this study because the data were obtained anonymously
from observational check-up data. In addition, in Japan,
subjects are not required to approve or disapprove the use
of anonymous information from medical check-up data
for research. All data were analyzed anonymously, and
thorough care was taken to prevent assessed individuals
from suffering any disadvantages.
Study subjects
Data were from 64,762 individuals who underwent
comprehensive health check-ups during the period
from April 1, 1999 to March 31, 2009 at the Yamanashi
Koseiren Health Care Center. The criteria for inclusion
were undergoing at least two health check-ups over the
5-year period from April 1999 to March 2004. During
the period, glycated hemoglobin A1c (HbA1c) and fast-
ing plasma glucose (FPG) levels of the study subjects
should not meet the Japanese diagnostic criteria for
prediabetes of HbA1c ≥ 6.5 % or FPG ≥ 126 mg/dL
(7.0 mmol/L) [14]. In addition to the criteria, the sub-
jects were eligible if they underwent at least one check-
up during the period from April 2004 to March 2009.
Patient and control definitions
Patients were defined as subjects who were newly diag-
nosed with diabetes at other hospitals outside or who
exhibited HbA1c ≥ 6.5 % or FPG ≥ 126 mg/dL during the
period from April 2004 to March 2009. Control healthy
subjects, whose HbA1c and FPG levels did not exceed
the diagnostic criteria for diabetes within the 10-year
survey period, were matched to diabetic patients for
BMI and age at a 1:10 ratio at the time of diabetes onset
of patients (time point 0). These operations were all per-
formed separately for males and females. The diagnostic
criteria were also based on the guidelines for epidemio-
logic research on diabetes by “Committee Report Re-
garding Diabetes Classifications and Diagnostic Criteria
(internationally standardized version)” [15]. Matching
was performed using an optimal matching [16].
Definitions of time points
The year of diabetes onset in the patient group was set
as time point 0. Each year was then measured with refer-
ence to time point 0. Thus, 1 year before onset was time
point −1, and 2 years before onset was time point −2. This
was continued to time point −9. Accordingly, time points
are expressed in years.
Clinical parameters
Clinical parameters included in our analysis comprised sex,
date of birth, height, weight, HbA1c, and FPG levels. Age
was calculated from date of birth. BMI was calculated as
weight in kilograms divided by square of height in meters.
Statistical analysis
We calculated mean and standard deviation (SD) values
for age, weight, height, BMI, HbA1c, and FPG levels for
each group at the matched time point. Student’s t test
compared baseline characteristics between patient and
control groups. As the major focus of this study, BMI tra-
jectory was subjected to regression analysis, using a linear
mixed-effects model that included time points, group cat-
egories, and interaction terms as explanatory categorical
variables. The group categories included diabetic patients
and healthy subjects, and the interaction terms were de-
fined between time points and group categories. The past
histories of the patient and control groups were reviewed,
and mean BMIs were estimated using the linear mixed-
effects model, from which a trajectory of each group was
drawn, stratified for sex. With the aim of taking individual
variability into consideration, a random effect for individ-
uals was set for the intercept of the linear mixed-effects
models. To assess whether increasing BMI affects the risk
for diabetes, P value for the difference in increasing BMIs
between patient and control groups was evaluated in an-
other simple fixed-effects model with interaction terms
that categorizes patient or control group and time points
0 or −9. All statistical analyses were performed using SAS
version 9.3 (Cary, NC, USA). All reporteP values are two-
sided; P values of <0.05 were considered to be statistically
significant.
Results
Figure 1 shows how eligible and matched control sub-
jects were selected. Table 1 represents the baseline charac-
teristics in patient and control groups. The mean ages of
males at the matching time point 0 were 59.3 (SD = 9.2)
years in the patient group and 57.7 (SD = 11.2) years in
the control group (P = 0.003), whereas the mean BMIs
were25.0 (SD = 3.1) kg/m2 in the patient group and 25.2
(SD = 2.9) kg/m2 in the control group (P = 0.22), respect-
ively. In females, the mean ages were 61.4 (SD = 7.9) years
in the patient group and 60.1 (SD = 9.6) years in the con-
trol group (P = 0.06), whereas the mean BMIs were 24.8
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(SD = 3.5) kg/m2 in the patient group and 24.9 (SD =
3.4) kg/m2 in the control group (P = 0.67), respectively.
Table 2 and Figs. 2 and 3 show the trajectories in pa-
tient and control groups. In males, the mean BMI was
consistently higher in the control group than in the pa-
tient group. In females, BMI also tended to be higher in
the control group than in the patient group. In contrast
to males, a lesser increase in BMI was observed over the
nine years in the female patient group than in the female
control group. Sudden increases in BMI were observed
in both male and female patients from one year before
diabetes onset. Statistically significant differences in BMI
as interaction terms were observed between the patient
and control groups at −1 (P = 0.01), −2 (P = 0.01), −3 (P =
0.045), and −4 (P = 0.0002) time points among males and
at −4 (P = 0.03), and −8 (P = 0.04) time points among fe-
males. The simple fixed-effects models, which examined
the major question of this study, represented P of 0.19 in
males and 0.67 in females between the increasing BMIs in
patient and control groups.
Discussion
The results of this study suggest that the retrospective
trajectories of BMIs in patients with newly-acquired
diabetes are similar to those in healthy individuals. To
the best of our knowledge, this is the first study compar-
ing BMI trajectories between Japanese individuals with
and without diabetes using repeated data.
Vistisen et al. described large changes in BMI in pa-
tients with diabetes in the UK without using matching
case to control [17], although typical BMI for the onset of
type 2 diabetes greatly differed between individuals of East
Asian descent and individuals of European descent [18].
Therefore, the present data may be specific to a type of
Japanese diabetic patients and hence may result in limited
generalizability. No previous reports described sudden in-
creases in BMI prior to diabetes onset. One Japanese
study, although performed over two time points, reported
that the risk for diabetes onset increased when either BMI
or body weight increased [19]. In a previous study,
Kodama et al. demonstrated that individuals of East Asian
descent with non-overweight or slightly overweight BMIs
also have a high risk of developing type 2 diabetes [6].
These studies are consistent with our results presenting
increasing but almost normal-ranged BMIs among the
diabetic patients.
The most likely mechanism for the diabetic onsets in
patient group is insulin resistance and impaired insulin
secretion in Japanese individuals with moderately high
and increasing BMI. According to a previous systematic
review, individuals of East Asian descent, which includes
Japanese people, have higher insulin sensitivity than
people from Western countries, whereas the insulin
secretory ability is low only in East Asian individuals
with diabetes. It has been reported that when the body
weight of an individual with impaired insulin secretion
increases, the risk of developing type 2 diabetes also in-
creases [6]. It appears that this mechanism is involved in
diabetes onset in patients in the present study. In another
study that identified a polymorphism involved in the onset
and progression of type 2 diabetes, the KCNJ15 poly-
morphism was observed in many non-overweight diabetic
patients of Japan, whose ability to secrete insulin tended
to decrease over time [20]. Although the patients and
healthy subjects in this study had not undergone genetic
testing, increased body weight in such individuals with
Fig. 1 Flowchart of study individuals
Table 1 Characteristics of diabetic patients and healthy subjects at the matching time of diabetes onset
Males Females
Variables, mean (SD) Case (n = 319) Control (n = 3170) P for difference Case (n = 146) Control (n = 1460) P for difference
Age, years 59.3 (9.2) 57.7 (11.2) 0.003 61.4 (7.9) 60.1 (9.6) 0.06
Weight, kg 69.9 (11.1) 70.8 (10.0) 0.13 57.6 (9.8) 59.3 (9.4) 0.047
Height, m 1.67 (0.07) 1.67 (0.06) 0.15 1.52 (0.06) 1.54 (0.06) 0.001
BMI, kg/m2 25.0 (3.1) 25.2 (2.9) 0.22 24.8 (3.5) 24.9 (3.4) 0.67
HbA1c, % 6.3 (0.6) 5.4 (0.3) <0.0001 6.4 (0.8) 5.5 (0.3) 0.0001
FPG, mg/dL 130 (13) 101 (8) <0.0001 129 (24) 98 (9) 0.0001
SD, standard deviation; BMI, body mass index; HbA1c, glycated hemoglobin A1c; FPG, fasting plasma glucose
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decreased insulin secretory ability may have increased in-
sulin resistance [21, 22] and it may have increased their
susceptibility to developing diabetes. Another pathway of
diabetic onset may be attributed to the observed fluctu-
ation in BMI prior to the onset of diabetes in this study.
Because literature suggests that weight fluctuation in-
creases the risk of type 2 diabetes in American women
[23], the observed fluctuation among the patient group
may have affected their insulin resistance [24]. Alterna-
tively, the observed fluctuation may reflect the small sam-
ple sizes of the male and female patient groups.
Literature is available on the sensitivity and specificity
for an HbA1c threshold of 6.5 %. Ito reports a sensitivity
of 53.4 % and a specificity of 94.6 % for an HbA1c
threshold of 6.5 % in a Japanese population [25]. In a
Chinese population, Bao et al. report a sensitivity of
53.7 % and a specificity of 97.4 % for an HbA1c thresh-
old of 6.5 % [26]. Because Choi et al. report a sensitivity
of 52 % and a specificity of 97 % for an HbA1c threshold
of 6.2 % in a Korean population, the sensitivity for an
HbA1c threshold of 6.5 % should be lower than 52 %
[27]. Furthermore, the latest data from the American
National Health and Nutrition Examination Survey de-
scribes a sensitivity of approximately 44 % and a specifi-
city of approximately 98 % at an HbA1c threshold of
6.5 % [28]. On the other hand, data from a Japanese
population has reported a sensitivity of 86.5 % and a
specificity of 87.3 % at the FPG threshold of 115 mg/dL
(6.4 mmol/L) [29]. Thus, the present epidemiologic-
research-based diagnosis for diabetes by the combination
of HbA1c ≥ 6.5 % or FPG ≥ 126 mg/dL [15] would have
achieved an acceptable sensitivity and specificity.
The strengths of this study include the fact that BMI
trajectories of both patients and controls were matched
for the timing of diabetes onset, the BMI, and the age.
Thus, this study is considered to have excluded the ef-
fect of having high BMI per se on the risk of developing
diabetes. Additionally, we used chronological data in
which BMIs were measured at three or more time
points. Although subjects were not identical at each time
point, it is noteworthy that the data depicted the trajec-
tories over 10 time points.
Table 2 Estimated mean BMIs before onsets of diabetes based on coefficients in mixed-effects models in patients and matched
healthy subjects
Time Points −9 −8 −7 −6 −5 −4 −3 −2 −1 0
Male
Diabetic patients 24.23 24.22 24.51 24.50 24.53 24.49 24.66 24.69 24.70 24.99
Healthy subjects 24.55 24.57 24.69 24.74 24.84 24.91 24.99 25.06 25.11 25.19
Female
Diabetic patients 24.31 24.12 24.09 24.29 24.18 24.21 24.51 24.48 24.51 24.75
Healthy subjects 24.08 23.86 24.23 24.41 24.50 24.58 24.67 24.77 24.81 24.89
Male
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Fig. 2 Retrospective BMI trajectories of patient and control groups by a linear mixed-effects model: Males
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A limitation of this study is that, in addition to the
interviews with the patients regarding their newly-
acquired diabetes, diabetes was partly diagnosed based
on HbA1c and FPG levels rather than on a confirmed
diagnosis from secondary tests or glucose tolerance
tests. Although we used criteria equivalent to parts of
the diagnostic criteria used by physicians in Japan
[14], and guidelines for epidemiologic research on dia-
betes allow for the use of the criteria applied in the
present study [15], it is possible that some subjects
were incorrectly classified as patient group subjects.
Results in Tables 1 and 2 show older ages and larger
weight gains from the previous year in the patient
group than the control group. Because people who are
either older or are gaining weight are more likely to
undergo health check-ups and be diagnosed with dia-
betes [30], the misclassification may have been differ-
ential and hence may have produced an associated
bias toward broadening the difference in BMI trajec-
tories between patient and control groups. The second
limitation of our study was that all subjects underwent a
paid comprehensive health check-up. Therefore, these re-
sults may not be directly applicable to the entire Japanese
population. Another limitation was the fact that because
this study used retrospective data from the time of disease
onset (time point 0), the population was not identical at
each observational time point. However, this had probably
only little effect, as no marked generational changes were
seen over the period from 1999 to 2009 in attitudes to-
ward health, diet, and exercise habits of Japanese people.
Furthermore, although adjustment by multivariate regres-
sion for confounding factors could be employed in this
study, we have exploited simple illustrations to compare
trajectories, matching patients and healthy subjects with
confounding factors.
This study suggests that the body weight of some pa-
tients with type 2 diabetes increases immediately before
disease onset. Therefore, healthy but pre-diabetic indi-
viduals whose body weight has been increasing for the
past few years should receive proactive guidance regard-
ing diet and exercise from their physicians, and they
should be encouraged to control their body weight. The
gradually increasing mean BMI of individuals with and
without diabetes in our study reached approximately 25
at the final measurement. This suggests that even if BMI
is within normal range (18.5–25), physicians should be
recommended to strongly advise East Asian adults not
to gain any weight.
Conclusions
The present study from large-scale clinical data of Japanese
residents suggests that the pace of increasing BMI in
diabetic patients is similar to that in healthy individuals.
The results also indicate that the BMIs of the Japanese
patients do not markedly increase prior to the onset of
type 2 diabetes.
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Fig. 3 Retrospective BMI trajectories of patient and control groups by a linear mixed-effects model: Females
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